Wolverine Trading
AVXL icon

Wolverine Trading’s Anavex Life Sciences AVXL Stock Holding History

Wolverine Trading’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$675K Buy
+78,000
New +$791K ﹤0.01% 3346
2025
Q2 		– Sell
-70,500
Closed -$615K – 4722
2025
Q1 		$615K Buy
70,500
+53,300
+310% +$503K ﹤0.01% 2742
2024
Q4 		$190K Buy
17,200
+6,200
+56% +$47.7K ﹤0.01% 4552
2024
Q3 		$62.5K Buy
+11,000
New +$63.5K ﹤0.01% 4488
2024
Q1 		– Sell
-27,000
Closed -$251K – 4479
2023
Q4 		$251K Buy
27,000
+13,500
+100% +$92.9K ﹤0.01% 3635
2023
Q3 		$88.4K Sell
13,500
-3,400
-20% -$27.1K ﹤0.01% 4033
2023
Q2 		$134K Sell
16,900
-5,600
-25% -$48K ﹤0.01% 3675
2023
Q1 		$187K Sell
22,500
-8,900
-28% -$88.8K ﹤0.01% 3446
2022
Q4 		$291K Sell
31,400
-18,000
-36% -$192K ﹤0.01% 2785
2022
Q3 		$482K Buy
49,400
+28,500
+136% +$301K ﹤0.01% 2634
2022
Q2 		$207K Sell
20,900
-3,400
-14% -$32.2K ﹤0.01% 3509
2022
Q1 		$298K Buy
+24,300
New +$299K ﹤0.01% 3892
2021
Q4 		– Sell
-24,000
Closed -$428K – 5783
2021
Q3 		$428K Buy
+24,000
New +$478K ﹤0.01% 4160

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wolverine Trading's AVXL Position: Q4 2024 in Review

Wolverine Trading sold out of Anavex Life Sciences (AVXL) in Q4 2024, closing a stake of 24,565 shares — an estimated $189K sold.

Wolverine Trading first reported a position in AVXL in Q2 2022 and held it in 4 quarters. The position peaked at $241K in Q3 2022. 168 funds tracked by Wall St. Rank hold AVXL as of Q4 2024.

  • Wolverine Trading reported no remaining Anavex Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 24,565 Anavex Life Sciences shares in Q4 2024, an estimated $189K.
  • Wolverine Trading first reported a position in Anavex Life Sciences in Q2 2022 and held it in 4 quarters.
  • Wolverine Trading's Anavex Life Sciences position peaked at $241K in Q3 2022.
  • 168 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.